A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Condition(s):Type 2 Diabetes MellitusLast Updated:November 6, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes MellitusLast Updated:November 6, 2018Completed
Condition(s):Solid TumoursLast Updated:July 24, 2017Completed
Condition(s):HydrationLast Updated:December 14, 2023Active, not recruiting
Condition(s):Skin Fold; Skin Laxity; Skin Texture Disorder; Skin Depression; Skin Dryness; Hyperpigmentation; Atrophic Scar; Striae Distensae; Oxidative StressLast Updated:August 21, 2023Completed
Condition(s):Chronic Kidney Disease Mineral and Bone Disorder; Renal Osteodystrophy; Vascular Calcification; Hyperparathyroidism; Secondary, RenalLast Updated:September 21, 2023Completed
Condition(s):Testing Effect of InterventionLast Updated:May 3, 2006Completed
Condition(s):Degenerative Disc Disease; Chronic Lower Back Pain; Discogenic Pain; Intervertebral Disc Degeneration; Lumbar Disc Disease; Lumbar Disc Degeneration; Lumbar Disc PainLast Updated:January 27, 2021Unknown status
Condition(s):Head and Neck Cancer PatientsLast Updated:May 16, 2023Completed
Condition(s):Drug SafetyLast Updated:February 2, 2016Completed
Condition(s):Advanced Solid Tumors; Breast CancerLast Updated:October 31, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.